Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
2010
AGEs and Diabetic Retinopathy
2010
A Molecular basis for human hypersensitivity of aminoglyscoside antibiotics
1993
“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis
1996
Diabetic retinopathy
2010 Standout
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
1996 Standout
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: Long‐term followup of a cohort of 145 patients participating in randomized controlled studies
2002
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
IgG Subclass Deposits in Glomeruli of Lupus and Nonlupus Membranous Nephropathies
1994
Renal Fibrosis
2001
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
2006
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Molecular basis of the functionalpodocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains
2003
Monoclonal immunoglobulin deposition disease associated with membranous features
2008
Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features
2003
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Proliferative Glomerulonephritis with Monoclonal IgG Deposits
2009
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
2008
Dialysis delayed is death prevented: A clinical perspective on the RENAAL study
2003
Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic Glomerulonephritis
1988 Standout
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
1996
Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls
2006
Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria
1992
Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
2009
Nephrotic Syndrome in Diabetic Kidney Disease: An Evaluation and Update of the Definition
2009
Chronic kidney disease
2011 Standout
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Mitochondria: In Sickness and in Health
2012 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Increased Excretions of β<sub>2</sub>-Microglobulin, IL-6, and IL-8 and Decreased Excretion of Tamm-Horsfall Glycoprotein in Urine of Patients with Active Lupus nephritis
2000
Acute Renal Failure
1996 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Treatment of chronic kidney disease
2011
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Cryoglobulinemia and renal disease
2008
Neurodegeneration and Inflammation
2008
The Antiphospholipid Syndrome
2002 Standout
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
2004
Renal Monoclonal Immunoglobulin Deposition Disease
2001
Systemic Lupus Erythematosus
2011 Standout
Glutathione peroxidase 4–regulated neutrophil ferroptosis induces systemic autoimmunity
2021
The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial
2010
Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome
1995
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways
2000
Acyclovir-induced renal failure
1988
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Long-Term Complications of Diabetes Mellitus
1993 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
2002 Standout
Acute kidney injury following proton pump inhibitor therapy
2006
Histopathologic Classification of ANCA-Associated Glomerulonephritis
2010
Emerging drugs for diabetic retinopathy
2008
The Nephrotic Syndrome
1998
Pathogenesis and treatment of renal failure in multiple myeloma
2008
Role of Rituximab Therapy in Glomerulonephritis
2008
Diabetes and advanced glycation endproducts
2002
Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome
1995
The Intrarenal Vascular Lesions Associated with Primary Antiphospholipid Syndrome
1999
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Idiopathic focal segmental glomerulosclerosis
2003
Toxoplasmic Encephalitis in AIDS
1992 Standout
Sequential Therapies for Proliferative Lupus Nephritis
2004
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Frailty in elderly people
2013 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Current Recommendations and Future Prospects in the Treatment of Toxoplasmosis
1989
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Die Vancomycin-Antibiotica und der Kampf gegen resistente Bakterien
1999
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Cell Biology of the Glomerular Podocyte
2003 Standout
Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis
2001
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Advanced Glycation End Products
2006 Standout
The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
2006
The Hemodialysis (HEMO) Study: Rationale for Selection of Interventions
1996
The changing natural history of nephropathy in type I Diabetes
1985
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Review : Serological markers of disease activity in systemic lupus erythematosus
1995
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
A Self-Complexing [2]Catenane
2000 StandoutNobel
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
A genetically clamped renin transgene for the induction of hypertension
2002 StandoutNobel
Evidence‐based medicine: useful tools for decision making
2001
Advanced glycation and retinal pathology during diabetes.
2005
Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America
2005
In situ immune complex formation and glomerular injury
1980
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years
1983 Standout
Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension
1995
Focal segmental glomerulosclerosis in adults
2003
Systemic lupus erythematosus
2007
Resistance to vancomycin and teicoplanin: an emerging clinical problem
1990
Trovafloxacin is active against Toxoplasma gondii
1996
Multiple Myeloma
2011 Standout
Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes
2005
Pathologic differentiation between lupus and nonlupus membranous glomerulopathy
1983
Monoclonal Proteins and Renal Disease
1994
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
2005
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of Gerald B. Appel being referenced
Fludarabine treatment of cryoglobulinemic glomerulonephritis
2002
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
2009
Long-term follow-up of patients with lupus nephritis
1987
Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
2004
Cyclosporine: Nephrotoxic effects and guidelines for safe use in patients with rheumatoid arthritis
1992
Pauci-immune Crescentic Glomerulonephritis Superimposed on Diabetic Glomerulosclerosis
2008
Course and prognosis of human immunodeficiency virus-associated nephropathy
1989
Mycophenolate Mofetil for the Treatment of Interstitial Nephritis
2006
Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis
2003
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis
1999
Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial
2001
Heavy chain deposition disease: The disease spectrum
1999
Update on the treatment of lupus nephritis
2006
Angiotensin II receptor antagonists: Role in hypertension, cardiovascular disease, and renoprotection
2004
Lipid abnormalities in renal disease
1991
Hepatitis C Virus-Associated Glomerular Disease in Patients with Human Immunodeficiency Virus Coinfection
1999
Sulfadiazine-Associated Obstructive Nephropathy Occurring in a Patient With the Acquired Immunodeficiency Syndrome
1988
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
2001
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
2002
Kinetics of intravenous amoxicillin in patients on long‐term dialysis
1979
Tubulointerstitial Disease in Lupus Nephritis: Relationship to Immune Deposits, Interstitial Inflammation, Glomerular Changes, Renal Function, and Prognosis
1986
The Nephrotoxicity of Antimicrobial Agents
1977
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
2005
Renal Vein Thrombosis, Nephrotic Syndrome, and Systemic Lupus Erythematosus
1976
Vancomycin and the Kidney
1986
Renal Toxicity of Nonsteroidal Anti-Inflammatory Drugs1
2015
HIV infection and the kidney.
1997
THE COURSE AND TREATMENT OF LUPUS NEPHRITIS
1994
Anti-cardiolipin antibody and renal disease
1990
The Nephrotoxicity of Antimicrobial Agents
1977
Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis
1979
Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
1994
Focal Segmental Membranous Glomerulonephropathy Associated with Other Glomerular Diseases
1983
An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State.
2001
The Hyperlipidemia of the Nephrotic Syndrome
1985
Acute renal failure in patients with multiple myeloma
1984
Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study
2003
Renal pathology of human immunodeficiency virus infection.
1998
Wegener's Granulomatosis — Clinical-Pathologic Correlations and Long-Term Course
1981
Renal vascular complications of systemic lupus erythematosus.
1994
RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
1978
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)
2007